Determination of CKMB activity and protein concentration and their application in the diagnosis of AMI

Y Song1, J Zhong, L Zhao

  • 1First Hospital of Wuhan City, Wuhan 430022.

Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao
|July 5, 2003
PubMed

Insights

Measuring creatine kinase-MB (CKMB) protein levels identifies acute myocardial infarction (AMI) earlier than CKMB activity. Protein levels show distinct peak values, aiding earlier AMI diagnosis in patients.

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Cardiology

Background:

  • Acute myocardial infarction (AMI) diagnosis relies on cardiac biomarker analysis.
  • Creatine kinase-myocardial band (CKMB) is a key cardiac biomarker.
  • Assessing CKMB activity and protein concentration aids in diagnosing myocardial damage.

Purpose of the Study:

  • To compare the diagnostic utility of CKMB activity versus CKMB protein concentration for early AMI detection.
  • To analyze the temporal profiles of CKMB activity and protein in AMI patients.

Main Methods:

  • Enzyme activity and protein concentration of CKMB were measured.
  • Samples were collected from 19 AMI patients, 17 non-AMI patients, and 26 healthy controls.
  • Peak times and peak values of CKMB were analyzed.

Main Results:

  • Peak times for CKMB activity and protein were similar in AMI and non-AMI patients.
  • Peak values of CKMB protein concentration were significantly different compared to CKMB activity (F=50.1 vs F=5.3).
  • CKMB protein levels demonstrated greater discriminative power between patient groups.

Conclusions:

  • CKMB protein concentration measurement is a more sensitive and earlier indicator of AMI than CKMB activity.
  • Protein level analysis offers a faster diagnostic window for acute myocardial infarction.
  • This finding can improve the timely management of AMI patients.

Related Concept Videos